Artificial Intelligence in Cardiology Market to Grow with a CAGR of 12.06% through 2029F
Echocardiography
enhancement and technological advancements is expected to drive the Global
Artificial Intelligence in Cardiology Market growth in the forecast
period, 2025-2029.
According
to TechSci Research report, “Artificial Intelligence in Cardiology Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2019-2029F”, the Global Artificial Intelligence in
Cardiology Market stood at USD
739.90 million in 2023 and is anticipated to project steady growth in
the forecast period with a CAGR of 12.06% through
2029. The global artificial intelligence (AI) in cardiology market is
experiencing a transformative phase, marked by significant advancements in
technology, growing acceptance of AI-driven solutions, and increasing adoption
across various facets of cardiology practice. AI has emerged as a powerful tool
in cardiovascular healthcare, offering innovative approaches to diagnosis, risk
assessment, treatment planning, and patient management. This market segment
encompasses a wide range of AI applications, including image interpretation,
predictive analytics, precision medicine, and clinical decision support
systems, each designed to enhance clinical workflows, improve diagnostic
accuracy, and optimize patient outcomes.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Artificial Intelligence in Cardiology Market”
With
CVDs accounting for a significant portion of global mortality and morbidity,
there is a pressing need for more efficient and effective strategies to
prevent, diagnose, and treat these conditions. AI-powered solutions offer the
potential to address this challenge by leveraging large datasets, advanced
algorithms, and machine learning techniques to analyze complex cardiovascular
data, identify patterns, and extract actionable insights that can inform
clinical decision-making and improve patient care. Also, advancements in
medical imaging technology have paved the way for AI-driven image analysis
tools that can automate the interpretation of cardiac images such as
echocardiograms, angiograms, and cardiac MRI scans. These AI-based imaging
solutions enable faster and more accurate diagnosis of cardiac abnormalities,
facilitate early detection of disease, and support treatment planning by
providing clinicians with detailed insights into cardiac structure and
function.
AI-driven remote monitoring and digital health platforms are revolutionizing
cardiac care by enabling continuous monitoring of patients' vital signs,
detecting early signs of deterioration, and facilitating timely interventions
to prevent adverse events. These AI-powered telehealth solutions offer the
potential to extend the reach of cardiology services beyond traditional
healthcare settings, improve access to care, and enhance patient engagement and
adherence to treatment plans.
The
Global artificial intelligence in cardiology Market is segmented into
component, application, regional distribution, and company.
In
the global artificial intelligence in cardiology market, the software component
segment is poised to dominate in the coming years, consolidating its position
as the cornerstone of AI-driven innovations in cardiac care. Software solutions
serve as the primary vehicle for deploying AI algorithms and machine learning
models that power advanced diagnostic, monitoring, and decision support systems
in cardiology. These software platforms enable seamless integration with existing
healthcare IT infrastructure, facilitating interoperability, data sharing, and
scalability across diverse clinical settings.
The
rapid evolution of AI technologies necessitates continuous software updates and
algorithm refinements to stay abreast of emerging trends and clinical insights.
As such, healthcare providers and technology vendors are increasingly investing
in software development to enhance the performance, accuracy, and reliability
of AI-driven solutions for cardiology.
In
the global artificial intelligence in cardiology market, the segment poised for
dominance in the coming years is Cardiac Arrhythmias. Cardiac arrhythmias
represent a significant clinical challenge worldwide, contributing to
morbidity, mortality, and healthcare costs. The complexity of arrhythmia
diagnosis, risk stratification, and treatment necessitates advanced
technologies capable of precise detection and management. AI-based solutions
excel in analyzing electrocardiographic signals, identifying subtle arrhythmic
patterns, and predicting arrhythmia recurrence with high accuracy, thereby
enhancing clinical decision-making and patient outcomes.
The
growing prevalence of cardiac arrhythmias, coupled with the rising adoption of
wearable devices and remote monitoring solutions, amplifies the demand for
AI-driven arrhythmia detection and management tools. These solutions empower
patients and healthcare providers to monitor heart rhythm disturbances
continuously, enabling early intervention, personalized treatment, and improved
quality of life.
North
America is anticipated to emerge as the fastest-growing segment in the global
artificial intelligence in cardiology market. North America boasts a robust
healthcare infrastructure characterized by advanced technology adoption, strong
regulatory frameworks, and a burgeoning emphasis on innovation.
Following
closely behind, Europe emerges as the second most dominating region in the
global artificial intelligence in cardiology market. Europe benefits from a
well-established healthcare system, proactive regulatory environment, and
extensive collaborations between academia, industry, and government entities.
The region demonstrates a strong commitment to leveraging AI technologies to
address the challenges of cardiovascular diseases, driving innovation and
market expansion. With increasing investments in digital health initiatives, AI
research, and clinical trials, Europe presents significant opportunities for
growth and development in the AI in cardiology market.
Major
companies operating in Global Artificial Intelligence in
Cardiology Market are:
- IDOVEN
- Dia Imaging Analysis Ltd
- Ultromics Limited
- Tempus AI, Inc.
- Koninklijke Philips N.V
- UltraSight Inc.
- HeartVista Inc.
- RSIP Vision
- Cleerly, Inc.
- Viz.ai, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
future of the Artificial Intelligence in Cardiology Market is poised for
significant growth and transformation.
The integration of AI into electrocardiogram (ECG) analysis has
streamlined the detection of arrhythmias, ischemic events, and conduction
abnormalities. AI algorithms can analyze ECG signals in real-time, flagging
anomalies for further evaluation and reducing the risk of overlooked diagnoses.
This transformative capability holds immense promise for early disease
detection, risk stratification, and personalized treatment planning in
cardiology and thereby is anticipated for growth in coming years.,” said Mr.
Karan Chechi, Research Director, TechSci Research, a research-based management
consulting firm.
“Artificial Intelligence in Cardiology
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,
Segmented By Component (Hardware, Software Solutions, Services), By Application
(Cardiac Arrhythmias, Stroke, Ischemic Heart Disease /CAD, Others), By Region
and Competition, 2019-2029F”, has evaluated the future growth potential of Global
Artificial Intelligence in Cardiology Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Artificial Intelligence in Cardiology Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com